Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC) as of Q2 2019
As of 30 Jun 2019,
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,635,216 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, Atlas Venture Advisors, Inc., Aquilo Capital Management, LLC, VICTORY CAPITAL MANAGEMENT INC, Polar Capital LLP, Laurion Capital Management LP, BlueCrest Capital Management Ltd, Pentwater Capital Management LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
Investor
Option
Weight %
Change %
Value $
* Price
Shares
Share Change
Activity
Report Period
Compare Q2 2019 vs Q4 2025 Across Filers
Q4 2025 holders
108
Q2 2019 holders
14
Holder diff
-94
Investor
Q4 2025 Shares
Q2 2019 Shares
Share Diff
Share Chg %
Q4 2025 Value $
Q2 2019 Value $
Value Diff $
Value Chg %
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and, if you allow them, measure engagement and deliver
advertising. Analytics and marketing storage stay off until you grant
consent. By clicking on "Agree and continue", you declare your consent to
the use of the selected optional cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.